* Biora Therapeutics Inc BIOR.OQ BIOR.O is expected
to show a
rise in quarterly revenue when it reports results on November
14 for the period ending September 30 2024
* The San Diego California-based company is expected to
report
revenue of $210 thousand, according to the mean estimate from 2
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Biora Therapeutics Inc
is for
a loss of $3.85 per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Biora
Therapeutics Inc is 97.50, above its last closing price
of $2.64.
This summary was machine generated November 8 at 15:51 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)